1 | cure | 5,536 |
2 | dropout | 1,176 |
3 | responder | 1,081 |
4 | false-positive | 718 |
5 | fatality | 436 |
6 | drop-out | 431 |
7 | seroprotection | 336 |
8 | false-negative | 287 |
9 | stone-free | 277 |
10 | discount | 149 |
11 | case-fatality | 108 |
12 | live-birth | 91 |
13 | retear | 64 |
14 | livebirth | 52 |
15 | true-positive | 52 |
16 | screen-positive | 49 |
17 | seroresponse | 47 |
18 | lenient | 42 |
19 | linearized | 29 |
20 | non-progression | 28 |
21 | cure/improvement | 20 |
22 | no-show | 19 |
23 | loss-to-follow-up | 18 |
24 | non-recurrence | 18 |
25 | reattendance | 18 |
26 | peck | 16 |
27 | true-negative | 14 |
28 | faller | 13 |
29 | remitter | 13 |
30 | diary-dry | 12 |
31 | ever-smoking | 10 |
32 | rvte | 9 |
33 | seroprotection/seroconversion | 9 |
34 | 5-year-survival | 8 |
35 | ipprom | 8 |
36 | placebo-response | 8 |
37 | post-ovulatory | 8 |
38 | regraft | 8 |
39 | seizure-freedom | 8 |
40 | disease-control | 7 |
41 | re-tear | 7 |
42 | stone-expulsion | 7 |
43 | mixed-feeding | 6 |
44 | nonreturn | 6 |
45 | preprogression | 6 |
46 | seyll | 6 |
47 | simultaneity | 6 |
48 | double-digit | 5 |
49 | false-discovery | 5 |
50 | non-stability | 5 |
51 | slew | 5 |
52 | assessed-but-not-recruited | 4 |
53 | egg-reduction | 4 |
54 | freedom-from-failure | 4 |
55 | ho-cdi | 4 |
56 | non-error | 4 |
57 | noncure | 4 |
58 | sp/sc | 4 |
59 | spt-positive | 4 |
60 | take-home-baby | 4 |
61 | defaulter | 3 |
62 | disease-free-survival | 3 |
63 | hfh/hfuc | 3 |
64 | high-responder | 3 |
65 | immunovac-vp-4 | 3 |
66 | multiple-pregnancy | 3 |
67 | overcall | 3 |
68 | pnc/cr | 3 |
69 | psa50 | 3 |
70 | pt-positive | 3 |
71 | reoffense | 3 |
72 | reoxy | 3 |
73 | seroresponse/seroprotection | 3 |
74 | telomere-shortening | 3 |
75 | time-to-pregnancy | 3 |
76 | all-cancer | 2 |
77 | brachypter | 2 |
78 | cea-positive | 2 |
79 | census-tract-poverty | 2 |
80 | complete-remission | 2 |
81 | fall/injury | 2 |
82 | heterolysis | 2 |
83 | insulin-independence | 2 |
84 | pregnancy/implantation | 2 |
85 | probability-discounting | 2 |
86 | reccurrence | 2 |
87 | screen-positivity | 2 |
88 | svr-24 | 2 |
89 | switcher | 2 |
90 | treatment-switching | 2 |
91 | trial-completion | 2 |
92 | triport™ | 2 |
93 | unfruitful | 2 |
94 | .hospitalisation | 1 |
95 | 12,035 | 1 |
96 | 16,924 | 1 |
97 | 2-fold-more-likely-to-survive | 1 |
98 | 20/50/70/90 | 1 |
99 | 28-cure | 1 |
100 | 3-year-survival | 1 |
101 | 8-year-survival | 1 |
102 | accrual/attrition | 1 |
103 | acid-application | 1 |
104 | adjusted-mortality | 1 |
105 | albumin-excretion | 1 |
106 | carbohydrate-ingestion | 1 |
107 | cct-fed | 1 |
108 | clinical-cure | 1 |
109 | completion/retention | 1 |
110 | conversional | 1 |
111 | corneal-oxygen-uptake | 1 |
112 | cro-acquisition | 1 |
113 | cuckoldry | 1 |
114 | d-survival | 1 |
115 | death-in-the-ed | 1 |
116 | delta-strain | 1 |
117 | denominator-based | 1 |
118 | detection/sensitivity | 1 |
119 | developmentally-appropriate | 1 |
120 | disease-incidence | 1 |
121 | divorce/re-marriage | 1 |
122 | documentation-completion | 1 |
123 | down-grading | 1 |
124 | ecurrence | 1 |
125 | effective/inefficient | 1 |
126 | ehr-documented | 1 |
127 | electrocardio | 1 |
128 | failed-appointment | 1 |
129 | first-abortion | 1 |
130 | flavinogenie | 1 |
131 | gamma-exposure | 1 |
132 | generic-substitution | 1 |
133 | graft-loss | 1 |
134 | graft-survival | 1 |
135 | greater-than-linear | 1 |
136 | healing/healed | 1 |
137 | high-coincidence | 1 |
138 | high-failure | 1 |
139 | high-screening | 1 |
140 | high-twinning | 1 |
141 | idltr | 1 |
142 | infarction/mortality | 1 |
143 | lipids-testing | 1 |
144 | lock-up | 1 |
145 | maentel-haenszel | 1 |
146 | mix-based | 1 |
147 | mrd-negative | 1 |
148 | ms-sampling | 1 |
149 | myocardial-infarction | 1 |
150 | near-gas-kinetic | 1 |
151 | necking | 1 |
152 | negative-culture | 1 |
153 | negligable | 1 |
154 | number-operative | 1 |
155 | on-average | 1 |
156 | over-lengthening | 1 |
157 | over-standard | 1 |
158 | patient-retention | 1 |
159 | patient-year-adjusted | 1 |
160 | peak-prescribing | 1 |
161 | pecularities | 1 |
162 | per-injection | 1 |
163 | placebo-discontinuation | 1 |
164 | placebo.higher | 1 |
165 | placenta-positive | 1 |
166 | post-ce | 1 |
167 | rct-dropout | 1 |
168 | re-intubations | 1 |
169 | re-sprain | 1 |
170 | reburial | 1 |
171 | recovery/improvement | 1 |
172 | response/cure | 1 |
173 | rosuvastatin/placebo | 1 |
174 | scid-based | 1 |
175 | secondary-patency | 1 |
176 | seronconversion | 1 |
177 | seropositivity/seroprotection | 1 |
178 | similar.ovulation | 1 |
179 | slow-infusion | 1 |
180 | stroke/death/mi | 1 |
181 | studies.third-generation | 1 |
182 | susceptibility/wt | 1 |
183 | sustained-remission | 1 |
184 | tcpo₂/healing | 1 |
185 | tongue-flick | 1 |
186 | topo1-expressing | 1 |
187 | treat-and-release | 1 |
188 | treatment-relapse | 1 |
189 | treatment-retention | 1 |
190 | vaccine-coverage | 1 |
191 | vur-resolution | 1 |
192 | weeks.drop-out | 1 |
1 | .hospitalisation | 1 |
2 | 12,035 | 1 |
3 | 16,924 | 1 |
4 | 2-fold-more-likely-to-survive | 1 |
5 | 20/50/70/90 | 1 |
6 | 28-cure | 1 |
7 | 3-year-survival | 1 |
8 | 5-year-survival | 8 |
9 | 8-year-survival | 1 |
10 | accrual/attrition | 1 |
11 | acid-application | 1 |
12 | adjusted-mortality | 1 |
13 | albumin-excretion | 1 |
14 | all-cancer | 2 |
15 | assessed-but-not-recruited | 4 |
16 | brachypter | 2 |
17 | carbohydrate-ingestion | 1 |
18 | case-fatality | 108 |
19 | cct-fed | 1 |
20 | cea-positive | 2 |
21 | census-tract-poverty | 2 |
22 | clinical-cure | 1 |
23 | complete-remission | 2 |
24 | completion/retention | 1 |
25 | conversional | 1 |
26 | corneal-oxygen-uptake | 1 |
27 | cro-acquisition | 1 |
28 | cuckoldry | 1 |
29 | cure | 5,536 |
30 | cure/improvement | 20 |
31 | d-survival | 1 |
32 | death-in-the-ed | 1 |
33 | defaulter | 3 |
34 | delta-strain | 1 |
35 | denominator-based | 1 |
36 | detection/sensitivity | 1 |
37 | developmentally-appropriate | 1 |
38 | diary-dry | 12 |
39 | discount | 149 |
40 | disease-control | 7 |
41 | disease-free-survival | 3 |
42 | disease-incidence | 1 |
43 | divorce/re-marriage | 1 |
44 | documentation-completion | 1 |
45 | double-digit | 5 |
46 | down-grading | 1 |
47 | drop-out | 431 |
48 | dropout | 1,176 |
49 | ecurrence | 1 |
50 | effective/inefficient | 1 |
51 | egg-reduction | 4 |
52 | ehr-documented | 1 |
53 | electrocardio | 1 |
54 | ever-smoking | 10 |
55 | failed-appointment | 1 |
56 | fall/injury | 2 |
57 | faller | 13 |
58 | false-discovery | 5 |
59 | false-negative | 287 |
60 | false-positive | 718 |
61 | fatality | 436 |
62 | first-abortion | 1 |
63 | flavinogenie | 1 |
64 | freedom-from-failure | 4 |
65 | gamma-exposure | 1 |
66 | generic-substitution | 1 |
67 | graft-loss | 1 |
68 | graft-survival | 1 |
69 | greater-than-linear | 1 |
70 | healing/healed | 1 |
71 | heterolysis | 2 |
72 | hfh/hfuc | 3 |
73 | high-coincidence | 1 |
74 | high-failure | 1 |
75 | high-responder | 3 |
76 | high-screening | 1 |
77 | high-twinning | 1 |
78 | ho-cdi | 4 |
79 | idltr | 1 |
80 | immunovac-vp-4 | 3 |
81 | infarction/mortality | 1 |
82 | insulin-independence | 2 |
83 | ipprom | 8 |
84 | lenient | 42 |
85 | linearized | 29 |
86 | lipids-testing | 1 |
87 | live-birth | 91 |
88 | livebirth | 52 |
89 | lock-up | 1 |
90 | loss-to-follow-up | 18 |
91 | maentel-haenszel | 1 |
92 | mix-based | 1 |
93 | mixed-feeding | 6 |
94 | mrd-negative | 1 |
95 | ms-sampling | 1 |
96 | multiple-pregnancy | 3 |
97 | myocardial-infarction | 1 |
98 | near-gas-kinetic | 1 |
99 | necking | 1 |
100 | negative-culture | 1 |
101 | negligable | 1 |
102 | no-show | 19 |
103 | non-error | 4 |
104 | non-progression | 28 |
105 | non-recurrence | 18 |
106 | non-stability | 5 |
107 | noncure | 4 |
108 | nonreturn | 6 |
109 | number-operative | 1 |
110 | on-average | 1 |
111 | over-lengthening | 1 |
112 | over-standard | 1 |
113 | overcall | 3 |
114 | patient-retention | 1 |
115 | patient-year-adjusted | 1 |
116 | peak-prescribing | 1 |
117 | peck | 16 |
118 | pecularities | 1 |
119 | per-injection | 1 |
120 | placebo-discontinuation | 1 |
121 | placebo-response | 8 |
122 | placebo.higher | 1 |
123 | placenta-positive | 1 |
124 | pnc/cr | 3 |
125 | post-ce | 1 |
126 | post-ovulatory | 8 |
127 | pregnancy/implantation | 2 |
128 | preprogression | 6 |
129 | probability-discounting | 2 |
130 | psa50 | 3 |
131 | pt-positive | 3 |
132 | rct-dropout | 1 |
133 | re-intubations | 1 |
134 | re-sprain | 1 |
135 | re-tear | 7 |
136 | reattendance | 18 |
137 | reburial | 1 |
138 | reccurrence | 2 |
139 | recovery/improvement | 1 |
140 | regraft | 8 |
141 | remitter | 13 |
142 | reoffense | 3 |
143 | reoxy | 3 |
144 | responder | 1,081 |
145 | response/cure | 1 |
146 | retear | 64 |
147 | rosuvastatin/placebo | 1 |
148 | rvte | 9 |
149 | scid-based | 1 |
150 | screen-positive | 49 |
151 | screen-positivity | 2 |
152 | secondary-patency | 1 |
153 | seizure-freedom | 8 |
154 | seronconversion | 1 |
155 | seropositivity/seroprotection | 1 |
156 | seroprotection | 336 |
157 | seroprotection/seroconversion | 9 |
158 | seroresponse | 47 |
159 | seroresponse/seroprotection | 3 |
160 | seyll | 6 |
161 | similar.ovulation | 1 |
162 | simultaneity | 6 |
163 | slew | 5 |
164 | slow-infusion | 1 |
165 | sp/sc | 4 |
166 | spt-positive | 4 |
167 | stone-expulsion | 7 |
168 | stone-free | 277 |
169 | stroke/death/mi | 1 |
170 | studies.third-generation | 1 |
171 | susceptibility/wt | 1 |
172 | sustained-remission | 1 |
173 | svr-24 | 2 |
174 | switcher | 2 |
175 | take-home-baby | 4 |
176 | tcpo₂/healing | 1 |
177 | telomere-shortening | 3 |
178 | time-to-pregnancy | 3 |
179 | tongue-flick | 1 |
180 | topo1-expressing | 1 |
181 | treat-and-release | 1 |
182 | treatment-relapse | 1 |
183 | treatment-retention | 1 |
184 | treatment-switching | 2 |
185 | trial-completion | 2 |
186 | triport™ | 2 |
187 | true-negative | 14 |
188 | true-positive | 52 |
189 | unfruitful | 2 |
190 | vaccine-coverage | 1 |
191 | vur-resolution | 1 |
192 | weeks.drop-out | 1 |
1 | psa50 | 3 |
2 | 20/50/70/90 | 1 |
3 | immunovac-vp-4 | 3 |
4 | svr-24 | 2 |
5 | 16,924 | 1 |
6 | 12,035 | 1 |
7 | near-gas-kinetic | 1 |
8 | sp/sc | 4 |
9 | hfh/hfuc | 3 |
10 | death-in-the-ed | 1 |
11 | cct-fed | 1 |
12 | healing/healed | 1 |
13 | scid-based | 1 |
14 | denominator-based | 1 |
15 | mix-based | 1 |
16 | assessed-but-not-recruited | 4 |
17 | ehr-documented | 1 |
18 | patient-year-adjusted | 1 |
19 | linearized | 29 |
20 | over-standard | 1 |
21 | post-ce | 1 |
22 | reattendance | 18 |
23 | disease-incidence | 1 |
24 | high-coincidence | 1 |
25 | insulin-independence | 2 |
26 | reccurrence | 2 |
27 | ecurrence | 1 |
28 | non-recurrence | 18 |
29 | stone-free | 277 |
30 | divorce/re-marriage | 1 |
31 | on-average | 1 |
32 | vaccine-coverage | 1 |
33 | flavinogenie | 1 |
34 | corneal-oxygen-uptake | 1 |
35 | negligable | 1 |
36 | cure | 5,536 |
37 | 28-cure | 1 |
38 | clinical-cure | 1 |
39 | response/cure | 1 |
40 | noncure | 4 |
41 | high-failure | 1 |
42 | freedom-from-failure | 4 |
43 | gamma-exposure | 1 |
44 | negative-culture | 1 |
45 | treat-and-release | 1 |
46 | reoffense | 3 |
47 | placebo-response | 8 |
48 | seroresponse | 47 |
49 | treatment-relapse | 1 |
50 | developmentally-appropriate | 1 |
51 | rvte | 9 |
52 | mrd-negative | 1 |
53 | false-negative | 287 |
54 | true-negative | 14 |
55 | number-operative | 1 |
56 | cea-positive | 2 |
57 | placenta-positive | 1 |
58 | false-positive | 718 |
59 | true-positive | 52 |
60 | screen-positive | 49 |
61 | pt-positive | 3 |
62 | spt-positive | 4 |
63 | 2-fold-more-likely-to-survive | 1 |
64 | peak-prescribing | 1 |
65 | down-grading | 1 |
66 | mixed-feeding | 6 |
67 | treatment-switching | 2 |
68 | necking | 1 |
69 | ever-smoking | 10 |
70 | tcpo₂/healing | 1 |
71 | ms-sampling | 1 |
72 | high-screening | 1 |
73 | over-lengthening | 1 |
74 | telomere-shortening | 3 |
75 | high-twinning | 1 |
76 | topo1-expressing | 1 |
77 | probability-discounting | 2 |
78 | lipids-testing | 1 |
79 | live-birth | 91 |
80 | livebirth | 52 |
81 | ho-cdi | 4 |
82 | stroke/death/mi | 1 |
83 | peck | 16 |
84 | tongue-flick | 1 |
85 | reburial | 1 |
86 | conversional | 1 |
87 | d-survival | 1 |
88 | disease-free-survival | 3 |
89 | 3-year-survival | 1 |
90 | 5-year-survival | 8 |
91 | 8-year-survival | 1 |
92 | graft-survival | 1 |
93 | maentel-haenszel | 1 |
94 | overcall | 3 |
95 | seyll | 6 |
96 | disease-control | 7 |
97 | unfruitful | 2 |
98 | seizure-freedom | 8 |
99 | ipprom | 8 |
100 | re-sprain | 1 |
101 | delta-strain | 1 |
102 | stone-expulsion | 7 |
103 | seronconversion | 1 |
104 | seroprotection/seroconversion | 9 |
105 | non-progression | 28 |
106 | preprogression | 6 |
107 | sustained-remission | 1 |
108 | complete-remission | 2 |
109 | slow-infusion | 1 |
110 | acid-application | 1 |
111 | similar.ovulation | 1 |
112 | studies.third-generation | 1 |
113 | .hospitalisation | 1 |
114 | pregnancy/implantation | 2 |
115 | placebo-discontinuation | 1 |
116 | per-injection | 1 |
117 | seroprotection | 336 |
118 | seroresponse/seroprotection | 3 |
119 | seropositivity/seroprotection | 1 |
120 | myocardial-infarction | 1 |
121 | egg-reduction | 4 |
122 | trial-completion | 2 |
123 | documentation-completion | 1 |
124 | albumin-excretion | 1 |
125 | accrual/attrition | 1 |
126 | cro-acquisition | 1 |
127 | patient-retention | 1 |
128 | treatment-retention | 1 |
129 | completion/retention | 1 |
130 | first-abortion | 1 |
131 | carbohydrate-ingestion | 1 |
132 | vur-resolution | 1 |
133 | generic-substitution | 1 |
134 | nonreturn | 6 |
135 | rosuvastatin/placebo | 1 |
136 | electrocardio | 1 |
137 | lock-up | 1 |
138 | loss-to-follow-up | 18 |
139 | greater-than-linear | 1 |
140 | re-tear | 7 |
141 | retear | 64 |
142 | pnc/cr | 3 |
143 | all-cancer | 2 |
144 | responder | 1,081 |
145 | high-responder | 3 |
146 | switcher | 2 |
147 | placebo.higher | 1 |
148 | faller | 13 |
149 | defaulter | 3 |
150 | brachypter | 2 |
151 | remitter | 13 |
152 | non-error | 4 |
153 | idltr | 1 |
154 | pecularities | 1 |
155 | heterolysis | 2 |
156 | re-intubations | 1 |
157 | graft-loss | 1 |
158 | regraft | 8 |
159 | double-digit | 5 |
160 | effective/inefficient | 1 |
161 | lenient | 42 |
162 | cure/improvement | 20 |
163 | recovery/improvement | 1 |
164 | failed-appointment | 1 |
165 | discount | 149 |
166 | drop-out | 431 |
167 | weeks.drop-out | 1 |
168 | dropout | 1,176 |
169 | rct-dropout | 1 |
170 | susceptibility/wt | 1 |
171 | slew | 5 |
172 | no-show | 19 |
173 | take-home-baby | 4 |
174 | multiple-pregnancy | 3 |
175 | time-to-pregnancy | 3 |
176 | secondary-patency | 1 |
177 | diary-dry | 12 |
178 | cuckoldry | 1 |
179 | false-discovery | 5 |
180 | post-ovulatory | 8 |
181 | fall/injury | 2 |
182 | simultaneity | 6 |
183 | fatality | 436 |
184 | case-fatality | 108 |
185 | adjusted-mortality | 1 |
186 | infarction/mortality | 1 |
187 | non-stability | 5 |
188 | detection/sensitivity | 1 |
189 | screen-positivity | 2 |
190 | census-tract-poverty | 2 |
191 | reoxy | 3 |
192 | triport™ | 2 |